BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Paige Expands Single AI Application to Detect Common, Rare Variants, and Precursor Lesions to Cancer Across More Than 40 Organs and Tissues

  February 6, 2025

   · 

  3 min read
• Press Releases

  Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study in Hunter Syndrome (MPS II) with Tividenofusp Alfa

  February 6, 2025

   · 

  9 min read
• Press Releases

  CenExel Celebrates FDA Approval of JOURNAVX(TM), a Groundbreaking Non-Opioid Pain Treatment

  February 6, 2025

   · 

  2 min read
• Press Releases

  Medexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States

  Fiscal Q3 2025 revenue of $30.0 million, net income of $0.7 million, operating income of $3.8 million, and Adjusted EBITDA* of $5.8 million Management to host conference call at 8:00 AM Eastern time on Thursday, February 6, 2024

  February 6, 2025

   · 

  24 min read
• Press Releases

  Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

  February 6, 2025

   · 

  2 min read
• Press Releases

  Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

  February 6, 2025

   · 

  1 min read
• Press Releases

  ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry

  February 6, 2025

   · 

  4 min read
• Press Releases

  Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

  February 6, 2025

   · 

  1 min read
• Press Releases

  RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock

  February 6, 2025

   · 

  6 min read
• Press Releases

  AstraZeneca’s Full Year and Q4 2024 results

  February 6, 2025

   · 

  10 min read